CAPONE, EMILY
 Distribuzione geografica
Continente #
NA - Nord America 1.751
AS - Asia 1.197
EU - Europa 1.078
SA - Sud America 162
AF - Africa 36
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 4.226
Nazione #
US - Stati Uniti d'America 1.706
SG - Singapore 594
IT - Italia 337
CN - Cina 241
IE - Irlanda 158
VN - Vietnam 158
BR - Brasile 135
RU - Federazione Russa 127
SE - Svezia 96
DE - Germania 83
IN - India 56
FR - Francia 47
FI - Finlandia 46
GB - Regno Unito 46
TR - Turchia 41
UA - Ucraina 37
CA - Canada 23
HK - Hong Kong 19
ZA - Sudafrica 17
NL - Olanda 16
AR - Argentina 15
PL - Polonia 14
AT - Austria 13
BE - Belgio 13
BD - Bangladesh 10
IQ - Iraq 10
ES - Italia 9
JP - Giappone 9
AE - Emirati Arabi Uniti 8
KR - Corea 8
MX - Messico 8
CH - Svizzera 7
EG - Egitto 7
LT - Lituania 6
UZ - Uzbekistan 6
GR - Grecia 5
PK - Pakistan 5
CZ - Repubblica Ceca 4
JO - Giordania 4
EC - Ecuador 3
HR - Croazia 3
JM - Giamaica 3
KE - Kenya 3
MA - Marocco 3
MY - Malesia 3
NI - Nicaragua 3
TN - Tunisia 3
TW - Taiwan 3
VE - Venezuela 3
AZ - Azerbaigian 2
BB - Barbados 2
DK - Danimarca 2
DZ - Algeria 2
ID - Indonesia 2
IL - Israele 2
LB - Libano 2
PE - Perù 2
PH - Filippine 2
RO - Romania 2
RS - Serbia 2
UY - Uruguay 2
AO - Angola 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CL - Cile 1
CR - Costa Rica 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EU - Europa 1
GD - Grenada 1
GE - Georgia 1
HU - Ungheria 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MN - Mongolia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 4.226
Città #
Singapore 437
Chandler 207
San Jose 201
Dublin 156
Ashburn 140
The Dalles 82
Beijing 72
Jacksonville 71
Dallas 69
Santa Clara 63
Los Angeles 55
Pescara 53
Princeton 53
Chieti 46
Ho Chi Minh City 44
Ann Arbor 43
New York 43
Munich 35
Council Bluffs 31
Boardman 29
Altamura 27
Hanoi 27
Dong Ket 22
Buffalo 21
Dearborn 20
Izmir 18
Nanjing 18
Wilmington 18
Lappeenranta 17
Denver 16
Hong Kong 16
Montreal 16
Hefei 15
Tongling 15
Turku 14
Brussels 13
Frankfurt am Main 12
Johannesburg 12
Moscow 12
Stockholm 12
Warsaw 12
Brooklyn 11
L’Aquila 11
Nuremberg 11
Redondo Beach 11
São Paulo 11
Atlanta 10
Milan 10
Phoenix 10
Rome 10
Chennai 9
Da Nang 9
Helsinki 9
Houston 9
Pune 9
Orem 8
Southend 8
Tokyo 8
Cambridge 7
Falls Church 7
Haiphong 7
Hebei 7
London 7
Mumbai 7
Poplar 7
Seoul 7
Dubai 6
Rio de Janeiro 6
Tashkent 6
Vienna 6
Finale Ligure 5
Macerata 5
Nanchang 5
Ninh Bình 5
Norwalk 5
Perugia 5
Salvador 5
Seattle 5
Washington 5
Zurich 5
Amman 4
Baghdad 4
Belo Horizonte 4
Cairo 4
Castignano 4
Chicago 4
Cleveland 4
Collecorvino 4
Putignano 4
Querétaro 4
Redwood City 4
San Francisco 4
Shanghai 4
Shijiazhuang 4
Woodbridge 4
Zhengzhou 4
Amsterdam 3
Biên Hòa 3
Boston 3
Brno 3
Totale 2.653
Nome #
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance 215
EV20-mediated delivery of cytotoxic auristatin MMAF exhibits potent therapeutic efficacy in cutaneous melanoma 177
EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma 171
ABCC3 is a novel target for the treatment of pancreatic cancer 161
Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer 152
LGALS3BP antibody-drug-conjugate and its use for the treatment of cancer 150
ErbB-3 activation by NRG-1β sustains growth and promotes vemurafenib resistance in BRAF-V600E colon cancer stem cells (CSCs) 149
Secreted Gal-3BP is a novel promising target for non-internalizing Antibody–Drug Conjugates 149
Generation of a novel Antibody-Drug Conjugate targeting endosialin: potent and durable antitumor response in sarcoma 147
Repurposing a psychoactive drug for children with cancer: p27 Kip1-dependent inhibition of metastatic neuroblastomas by Prozac 147
Dual targeting of ErbB-2/ErbB-3 results in enhanced antitumor activity in preclinical models of pancreatic cancer. 132
HPLC-DAD validated method for DM4 and its metabolite S-Me-DM4 quantification in biological matrix for clinical and pharmaceutical applications 129
BAG3 induces fibroblasts to release key cytokines involved in pancreatic cell migration 129
Extracellular vesicles in glioblastoma: Biomarkers and therapeutic tools 126
Targeting vesicular lgals3bp by an antibody-drug conjugate as novel therapeutic strategy for neuroblastoma 124
Normal breathing releases SARS-CoV-2 into the air 123
HER-3 surface expression increases in advanced colorectal cancer representing a potential therapeutic target 120
EV20‑sss‑vc/MMAF, an HER‑3 targeting antibody‑drug conjugate displays antitumor activity in liver cancer 115
Antibody-drug conjugates: The new frontier of chemotherapy 110
HER3 targeting with an antibody-drug conjugate bypasses resistance to anti-HER2 therapies 109
Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancer 109
Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma 108
Extracellular LGALS3BP: a potential disease marker and actionable target for antibody-drug conjugate therapy in glioblastoma 105
EV20, a Novel Anti-ErbB-3 Humanized Antibody, Promotes ErbB-3 Down-Regulation and Inhibits Tumor Growth In Vivo. 105
Dual PDK1/aurora kinase a inhibitors reduce pancreatic cancer cell proliferation and colony formation 100
LGALS3BP antibody-drug conjugate enhances tumor-infiltrating lymphocytes and synergizes with immunotherapy to restrain neuroblastoma growth 97
HER-3: Hub for escape mechanisms 95
Endosialin-binding antibody 92
EV20/NMS-P945, a Novel Thienoindole Based Antibody-Drug Conjugate Targeting HER-3 for Solid Tumors 90
MYC regulates metabolism through vesicular transfer of glycolytic kinases 84
EV20/Omomyc: A novel dual MYC/HER3 targeting immunoconjugate 81
Visualizing Galectin-3 Binding Protein Expression with ImmunoPET 77
LGALS3BP is a potential target of antibody-drug conjugates in oral squamous cell carcinoma 77
Evaluation of Antibody-Drug Conjugate Performances Using a Novel HPLC-DAD Method for Tumor-Specific Detection of DM4 and S-Methyl-DM4 71
A first-in-class non-cytotoxic nanocarrier based on a recombinant human ferritin boosts targeted therapy, chemotherapy and immunotherapy 68
Role of galectin 3 binding protein in cancer progression: a potential novel therapeutic target 61
Therapeutic potential of antibody‐drug conjugate‐based therapy in head and neck cancer: A systematic review 60
Osimertinib and anti-HER3 combination therapy engages immune dependent tumor toxicity via STING activation in trans 57
Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker 35
Totale 4.407
Categoria #
all - tutte 17.411
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.411


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202165 0 0 0 0 0 0 0 0 0 25 8 32
2021/2022175 6 3 4 25 16 11 11 12 17 8 14 48
2022/2023539 43 97 35 65 46 86 20 45 64 12 18 8
2023/2024343 18 10 41 17 18 111 49 12 0 14 11 42
2024/20251.022 34 180 162 53 21 39 42 48 128 69 152 94
2025/20261.761 154 70 138 218 228 131 382 97 180 163 0 0
Totale 4.407